Financhill
Back

Precigen Quote, Financials, Valuation and Earnings

Precigen Price Quote

$0.95
+0.05 (+5.22%)
(Updated: November 22, 2024 at 12:25 PM ET)

Precigen Key Stats

Sell
47
Precigen (PGEN) is a Sell

Day range:
$0.83 - $0.93
52-week range:
$0.77 - $1.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
58.46
P/B ratio:
4.78%

Volume:
795.5K
Avg. volume:
747.9K
1-year change:
-18.29%
Market cap:
$264.4M
Revenue:
$6.2M
EPS:
$-0.55

How Much Does Precigen Make?

  • How Much Are Precigen's Sales Annually?
    PGEN Revenues are $6.2M
  • How Much Profit Does Precigen's Make A Year?
    PGEN net income is -$95.9M

Is Precigen Growing As A Company?

  • What Is Precigen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.31%
  • What Is Precigen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Precigen Stock Price Performance

  • Did Precigen Stock Go Up Last Month?
    Precigen share price went down by -2.62% last month
  • Did PGEN's Share Price Rise Over The Last Year?
    PGEN share price fell by -18.29% over the past 1 year

What Is Precigen 52-Week High & Low?

  • What Is Precigen’s 52-Week High Share Price?
    Precigen has traded as high as $1.93 over the past 52 weeks
  • What Is Precigen’s 52-Week Low Share Price?
    Precigen has traded as low as $0.77 over the past 52 weeks

Precigen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Precigen?

  • How Much Debt Does Precigen Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Precigen Have?
    Cash and short term investments quarterly total is $28.6M
  • What Is Precigen’s Book Value Per Share?
    Book value per share is 0.19

Is Precigen Cash Flow Positive?

  • What Is PGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$75.7M
  • What Is Precigen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $32.2M
  • What Is Precigen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $57.9M

Precigen Return On Invested Capital

  • Is Management Doing A Good Job?
    PGEN return on invested capital is -151.13%
  • What Is Precigen Return On Assets?
    ROA measures how assets are converting to revenues and is -110.2%
  • What Is PGEN Return On Equity?
    ROE is a measure of profitability and is -151.13%

Precigen Earnings Date & Stock Price

  • What Is Precigen's Stock Price Today?
    A single share of PGEN can be purchased today for 0.90
  • What Is Precigen’s Stock Symbol?
    Precigen trades on the nasdaq under the ticker symbol: PGEN
  • When Is Precigen’s Next Earnings Date?
    The next quarterly earnings date for Precigen is scheduled on March 19, 2025
  • When Is PGEN's next ex-dividend date?
    Precigen's next ex-dividend date is November 22, 2024
  • How To Buy Precigen Stock?
    You can buy Precigen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Precigen Competitors

  • Who Are Precigen's Competitors?
    Below is a list of companies who compete with Precigen or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • GlycoMimetics Inc (GLYC)
    • Lexicon Pharmaceuticals Inc (LXRX)

Precigen Dividend Yield

  • What Is PGEN Dividend Yield?
    Precigen’s dividend yield currently is 0%
  • What Is Precigen’s Payout Ratio?
    Precigen’s payout ratio is 0%
  • When Did Precigen Last Pay A Dividend?
    The latest dividend pay date is November 22, 2024
  • What Is Precigen’s Dividend Per Share?
    Precigen pays a dividend of $0.00 per share

Precigen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.09%
Revenue: -30.89% -25.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 564.53%

Major Shareholders

  • How many PGEN shares are owned by institutional investors?
    88.2M PGEN shares are owned by institutional investors
  • How many PGEN shares are owned by insiders?
    10M PGEN shares are owned by insiders